Linden Thomas Advisory Services LLC increased its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 13.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 42,450 shares of the biopharmaceutical company’s stock after purchasing an additional 5,126 shares […]